From the Editor
A dvances in technology have brought forth many changes in cochlear implants. Just several years ago, a general review of cochlear implant coding strategies was sufficient to capture the differences among cochlear implants. In recent years, the signal-processing and speech-coding strategies implemented in cochlear implants from different manufacturers have become more divergent. In this issue, 2 cochlear implant manufacturers provide updates on their cochlear implant systems and discuss future directions of cochlear implants.
In the first article, Patrick, Busby, and Gibson provide an overview of the evolution of Nucleus cochlear implant systems and the rationale behind the development of the Nucleus Freedom system. They also discuss issues related to the reliability of cochlear implants, new electrode array options, bilateral cochlear implants, combined electroacoustic stimulation, advances in coding strategies, and improvements in programming paradigms.
In the second article, Hochmair, Nopp, Jolly, Schößer, Garnham, Schmidt, and Anderson review the rationale behind the development of the MED-EL MAESTRO cochlear implant system and describe its features and a new speech-coding strategy. In addition, they provide updates on the research and development of bilateral cochlear implants, newly integrated devices for combined electroacoustic stimulation, and the concept and preliminary results of a drug-delivery system through cochlear implants.
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